Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/568
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJabbarov Ozim-
dc.date.accessioned2020-03-18T04:12:51Z-
dc.date.available2020-03-18T04:12:51Z-
dc.date.issued2019-
dc.identifier.issn2181-9750-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/568-
dc.description.abstractThe purpose of the current study was to find out the correlation and cause effect relationship between LDL cholesterol and nephropathy in diabetic population. Type-2 diabetes mellitus is an increasingly common metabolic abnormality associated with microvascular and macrovascular complications. It is also the most common cause of end stage renal disease (ESRD). Lipoprotein (Lp) is a recently discussed important independent and inheritable risk factor for micro and macrovascular complications and also an independent risk factor for the progression of diabetic nephropathy in DM2 patients with overt proteinuria.en_US
dc.language.isootheren_US
dc.publisherTashkenten_US
dc.relation.ispartofseriesUDC;616.153.915:616.379-008.64:616.61-
dc.subjectDiabetes, Dyslipidemia, LDL-Cholesterol, Microalbuminuria, Nephropathy, Renal diaseaseen_US
dc.titleThe role of lipoproteins in the development of diabetic nephropathia in patients with diabetes mellitus type 2en_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
76..pdfThe role of lipoproteins in the development of diabetic nephropathia in patients with diabetes mellitus type 2323.67 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.